Nuclear receptor interactions in methotrexate induction of human dehydroepiandrosterone sulfotransferase (hSULT2A1)

Journal of Biochemical and Molecular Toxicology

Volumn 20, Issue 6, 2006, Pages 309-317

  Chen, Xinrong ^a   Maiti, Smarajit ^a   Zhang, Jimei ^b   Chen, Guangping ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b TIANJIN POLYTECHNIC UNIVERSITY   (China)

Author keywords

Gene Regulation; Methotrexate; Nuclear Receptors; Sulfotransferases 2A1

Indexed keywords

CELL NUCLEUS RECEPTOR; COLECALCIFEROL; CONSTITUTIVE ACTIVE RECEPTOR; HYDROXYSTEROID; METHOTREXATE; PRASTERONE SULFOTRANSFERASE; PREGNANE X RECEPTOR; SULFOTRANSFERASE; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; XENOBIOTIC AGENT;

ARTICLE; CELL STRAIN CACO 2; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GENE CONTROL; GENE EXPRESSION; GENE VECTOR; HORMONE ACTION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PROMOTER REGION; SIGNAL TRANSDUCTION; SULFONATION;

ANTIMETABOLITES, ANTINEOPLASTIC; ENZYME INDUCTION; GENE EXPRESSION; GENES, REPORTER; HUMANS; METHOTREXATE; PROMOTER REGIONS (GENETICS); RECEPTORS, CALCITRIOL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; SULFOTRANSFERASES; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 33845910657     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.20149     Document Type: Article

References (28)

1. Runge-Morris M, Kocarek TA. Regulation of sulfotransferases by xenobiotic receptors. Curr Drug Metab 2005;6(4):299-307.
2. Coughtrie MW. Sulfation through the looking glass-recent advances in sulfotransferase research for the curious. Pharmacogenomics J 2002;2(5):297-308.
3. Duffel MW, Marshal AD, McPhie P, Sharma V, Jakoby WB. Enzymatic aspects of the phenol (aryl) sulfotransferases. Drug Metab Rev 2001;33(3/4):369-395.
4. Gamage N, Barnett A, Hempel N, Duggleby RG, Windmill KF, Martin JL, McManus ME. Human sulfotransferases and their role in chemical metabolism. Toxicol Sci 2006;90(1):5-22.
5. Coughtrie MW, Sharp S, Maxwell K, Innes NP. Biology and function of the reversible sulfation pathway catalysed by human sulfotransferases and sulfatases. Chem Biol Interact 1998;109(1-3):3-27.
6. Nimmagadda D, Cherala G, Ghatta S. Cytosolic sulfotransferases. Indian J Exp Biol 2006;44(3):171-182.
7. Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev 2001;81(3):1269-1304.
8. Song CS, Echchgadda I, Baek BS, Ahn SC, Oh T, Roy AK, Chatterjee B. Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor. J Biol Chem 2001;276(45):42549-42556.
9. Sonoda J, Xie W, Rosenfeld JM, Barwick JL, Guzelian PS, Evans RM. Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proc Natl Acad Sci USA 2002;99(21):13801-13806.
10. Kim MS, Shigenaga J, Moser A, Grunfeld C, Feingold KR. Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response. Am J Physiol Endocrinol Metab 2004;287(4):E731-E738.
11. Echchgadda I, Song CS, Roy AK, Chatterjee B. Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor. Mol Pharmacol 2004;65(3):720-729.
12. Kitada H, Miyata M, Nakamura T, Tozawa A, Honma W, Shimada M, Nagata K, Sinai CJ, Guo GL, Gonzalez FJ, Yamazoe Y. Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity. J Biol Chem 2003;278(20):17838-44.
13. Assem M, Schuetz EG, Leggas M, Sun D, Yasuda K, Reid G, Zelcer N, Adachi M, Strom S, Evans RM, Moore DD, Borst P, Schuetz JD. Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice. J Biol Chem 2004;279(21):22250-22257.
14. Saini SP, Sonoda J, Xu L, Toma D, Uppal H, Mu Y, Ren S, Moore DD, Evans RM, Xie W. A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification. Mol Pharmacol 2004;65(2):292-300.
15. Foeldvari I, Wierk A. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. J Rheumatol 2005;32(2):362-365.
16. Soon SY, Ansari A, Yaneza M, Raoof S, Hirst J, Sanderson JD. Experience with the use of low-dose methotrexate for inflammatory bowel disease. Eur J Gastroenterol Hepatol 2004;16(9):921-926.
17. Borchers AT, Keen CL, Cheema GS, Gershwin ME. The use of methotrexate in rheumatoid arthritis. Semin Arthritis Rheum 2004;34(1):465-483.
18. Chen J, Liu C. Methotrexate for ankylosing spondylitis. Cochrane Database Syst Rev 2004(3):CD004524.
19. Cheung RL, Lee C, Jones EJ, Riddick DS. Lack of effect of methotrexate on the expression of constitutive hepatic cytochromes P450 in the male rat. Xenobiotica 1996;26(5):503-514.
20. Maiti S, Chen G. Methotrexate is a novel inducer of rat liver and intestinal sulfotransferases. Arch Biochem Biophys 2003;418(2):161-168.
21. Chen X, Baker SM, Chen G. Methotrexate induction of human sulfotransferases in Hep G2 and Caco-2 cells. J Appl Toxicol 2005;25(5):354-360.
22. Maiti S, Chen X, Chen G. All-trans retinoic acid induction of sulfotransferases. Basic Clin Pharmacol Toxicol 2005;96(1):44-53.
23. Otterness DM, Her C, Aksoy S, Kimura S, Wieben ED, Weinshilboum RM. Human dehydroepiandrosterone sulfotransferase gene: molecular cloning and structural characterization. DNA Cell Biol 1995;14(4):331-341.
24. Duanmu Z, Locke D, Smigelski J, Wu W, Dann MS, Falany CN, Kocarek TA, Runge-Morris M. Effects of dexamethasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes. Drug Metab Dispos 2002;30(9):997-1004.
25. Xu RX, Lambert MH, Wisely BB, Warren EN, Weinert EE, Waitt GM, Williams JD, Collins JL, Moore LB, Willson TM, Moore JT. A structural basis for constitutive activity in the human CAR/RXRalpha heterodimer. Mol Cell 2004;16(6):919-928.
26. Shulman AI, Larson C, Mangelsdorf DJ, Ranganathan R. Structural determinants of allosteric ligand activation in RXR heterodimers. Cell 2004;116(3):417-429.
27. Laflamme L, Hamann G, Messier N, Maltais S, Langlois MF. RXR acts as a coregulator in the regulation of genes of the hypothalamo-pituitary axis by thyroid hormone receptors. J Mol Endocrinol 2002;29(1):61-72.
28. Song CS, Echchgadda I, Seo YK, Oh T, Kim S, Kim SA, Cho S, Shi L, Chatterjee B. An essential role of the CAAT/enhancer binding protein-alpha in the vitamin D-induced expression of the human steroid/bile acid-sulfotransferase (SULT2A1). Mol Endocrinol 2006;20(4):795-808.